Cambridge synthetic biology startup inks $1B collaboration with Merck

The Cambridge-based startup said the collaboration will initially focus on the discovery and development of biologic cancer treatments.

Source: bizjournals.com Health Care:Biotechnology headlines - March 12, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news